Anti-Obesity Drugs Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (Peripherally Acting Anti-obesity Drugs, Centrally Acting Anti-obesity Drugs), By Applications (Kids, Adults), Regional Insights and Forecast to 2035
- Last Updated: 04-November-2026
- Base Year: 2025
- Historical Data: 2021 - 2024
- Region: Global
- Format: PDF
- Report ID: GGI106373
- SKU ID: 30505617
- Pages: 109
Download FREE Sample
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Anti-Obesity Drugs Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Anti-Obesity Drugs Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Anti-Obesity Drugs Business Mode and Production Process
2.3.1 Anti-Obesity Drugs Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Anti-Obesity Drugs Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Anti-Obesity Drugs
2.4.2 Raw Material Cost of Anti-Obesity Drugs
2.4.3 Labor Cost of Anti-Obesity Drugs
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global Anti-Obesity Drugs Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Anti-Obesity Drugs Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Anti-Obesity Drugs Price by Manufacturer (2021-2026)
4.4 Anti-Obesity Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Anti-Obesity Drugs, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Anti-Obesity Drugs, Product Offered and Application
4.7 Anti-Obesity Drugs Market Competitive Situation and Trends
4.7.1 Anti-Obesity Drugs Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Anti-Obesity Drugs Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global Anti-Obesity Drugs Market Historical Development by Geographic Region (2021-2026)
5.1 Global Anti-Obesity Drugs Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Anti-Obesity Drugs Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Anti-Obesity Drugs Market Status by Country (2021-2026)
5.3.1 North America Anti-Obesity Drugs Sales Volume by Country (2021-2026)
5.3.2 North America Anti-Obesity Drugs Revenue by Country (2021-2026)
5.3.3 United States Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Anti-Obesity Drugs Market Status by Country (2021-2026)
5.4.1 Europe Anti-Obesity Drugs Sales Volume by Country (2021-2026)
5.4.2 Europe Anti-Obesity Drugs Revenue by Country (2021-2026)
5.4.3 Germany Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Anti-Obesity Drugs Market Status by Country (2021-2026)
5.5.1 Asia Pacific Anti-Obesity Drugs Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Anti-Obesity Drugs Revenue by Country (2021-2026)
5.5.3 China Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Anti-Obesity Drugs Market Status by Country (2021-2026)
5.6.1 Latin America Anti-Obesity Drugs Sales Volume by Country (2021-2026)
5.6.2 Latin America Anti-Obesity Drugs Revenue by Country (2021-2026)
5.6.3 Mexico Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Anti-Obesity Drugs Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Anti-Obesity Drugs Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Anti-Obesity Drugs Revenue by Country (2021-2026)
5.7.3 GCC Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Anti-Obesity Drugs Sales Volume, Revenue and Growth (2021-2026)
6 Global Anti-Obesity Drugs Market Historical Development by Product Type (2021-2026)
6.1 Anti-Obesity Drugs Definition by Type
6.2 Global Anti-Obesity Drugs Historical Sales Volume by Product Type (2021-2026)
6.3 Global Anti-Obesity Drugs Historical Revenue by Product Type (2021-2026)
6.4 Global Anti-Obesity Drugs Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Anti-Obesity Drugs Historical Sales Volume, Revenue and Growth Rate of Peripherally Acting Anti-obesity Drugs (2021-2026)
6.5.2 Global Anti-Obesity Drugs Historical Sales Volume, Revenue and Growth Rate of Centrally Acting Anti-obesity Drugs (2021-2026)
7 Global Anti-Obesity Drugs Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Anti-Obesity Drugs Historical Sales Volume by End User (2021-2026)
7.3 Global Anti-Obesity Drugs Historical Revenue by End User (2021-2026)
7.4 Global Anti-Obesity Drugs Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Anti-Obesity Drugs Historical Sales Volume, Revenue and Growth Rate of Kids (2021-2026)
7.5.2 Global Anti-Obesity Drugs Historical Sales Volume, Revenue and Growth Rate of Adults (2021-2026)
8 Leading Companies Profiles
8.1 Eisai
8.1.1 Eisai Corporation Information
8.1.2 Eisai - Anti-Obesity Drugs Product Portfolio and Specification
8.1.3 Eisai Performance Analysis (2021-2026)
8.1.4 Eisai Business and Markets Served
8.1.5 Eisai Recent Developments
8.2 Boehringer Ingelheim
8.2.1 Boehringer Ingelheim Corporation Information
8.2.2 Boehringer Ingelheim - Anti-Obesity Drugs Product Portfolio and Specification
8.2.3 Boehringer Ingelheim Performance Analysis (2021-2026)
8.2.4 Boehringer Ingelheim Business and Markets Served
8.2.5 Boehringer Ingelheim Recent Developments
8.3 Amylin
8.3.1 Amylin Corporation Information
8.3.2 Amylin - Anti-Obesity Drugs Product Portfolio and Specification
8.3.3 Amylin Performance Analysis (2021-2026)
8.3.4 Amylin Business and Markets Served
8.3.5 Amylin Recent Developments
8.4 Orexigen Therapeutics
8.4.1 Orexigen Therapeutics Corporation Information
8.4.2 Orexigen Therapeutics - Anti-Obesity Drugs Product Portfolio and Specification
8.4.3 Orexigen Therapeutics Performance Analysis (2021-2026)
8.4.4 Orexigen Therapeutics Business and Markets Served
8.4.5 Orexigen Therapeutics Recent Developments
8.5 Roche
8.5.1 Roche Corporation Information
8.5.2 Roche - Anti-Obesity Drugs Product Portfolio and Specification
8.5.3 Roche Performance Analysis (2021-2026)
8.5.4 Roche Business and Markets Served
8.5.5 Roche Recent Developments
8.6 GlaxoSmithKline
8.6.1 GlaxoSmithKline Corporation Information
8.6.2 GlaxoSmithKline - Anti-Obesity Drugs Product Portfolio and Specification
8.6.3 GlaxoSmithKline Performance Analysis (2021-2026)
8.6.4 GlaxoSmithKline Business and Markets Served
8.6.5 GlaxoSmithKline Recent Developments
8.7 Pfizer
8.7.1 Pfizer Corporation Information
8.7.2 Pfizer - Anti-Obesity Drugs Product Portfolio and Specification
8.7.3 Pfizer Performance Analysis (2021-2026)
8.7.4 Pfizer Business and Markets Served
8.7.5 Pfizer Recent Developments
8.8 Novo Nordisk
8.8.1 Novo Nordisk Corporation Information
8.8.2 Novo Nordisk - Anti-Obesity Drugs Product Portfolio and Specification
8.8.3 Novo Nordisk Performance Analysis (2021-2026)
8.8.4 Novo Nordisk Business and Markets Served
8.8.5 Novo Nordisk Recent Developments
8.9 Alizyme
8.9.1 Alizyme Corporation Information
8.9.2 Alizyme - Anti-Obesity Drugs Product Portfolio and Specification
8.9.3 Alizyme Performance Analysis (2021-2026)
8.9.4 Alizyme Business and Markets Served
8.9.5 Alizyme Recent Developments
8.10 Vivus
8.10.1 Vivus Corporation Information
8.10.2 Vivus - Anti-Obesity Drugs Product Portfolio and Specification
8.10.3 Vivus Performance Analysis (2021-2026)
8.10.4 Vivus Business and Markets Served
8.10.5 Vivus Recent Developments
8.11 Merck
8.11.1 Merck Corporation Information
8.11.2 Merck - Anti-Obesity Drugs Product Portfolio and Specification
8.11.3 Merck Performance Analysis (2021-2026)
8.11.4 Merck Business and Markets Served
8.11.5 Merck Recent Developments
8.12 Arena Pharmaceuticals
8.12.1 Arena Pharmaceuticals Corporation Information
8.12.2 Arena Pharmaceuticals - Anti-Obesity Drugs Product Portfolio and Specification
8.12.3 Arena Pharmaceuticals Performance Analysis (2021-2026)
8.12.4 Arena Pharmaceuticals Business and Markets Served
8.12.5 Arena Pharmaceuticals Recent Developments
9 Global Anti-Obesity Drugs Market Forecast by Product Type and End User (2026-2035)
9.1 Global Anti-Obesity Drugs Market Forecast by Product Type (2026-2035)
9.1.1 Global Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth Rate of Peripherally Acting Anti-obesity Drugs (2026-2035)
9.1.2 Global Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth Rate of Centrally Acting Anti-obesity Drugs (2026-2035)
9.2 Global Anti-Obesity Drugs Market Forecast by End User (2026-2035)
9.2.1 Global Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth Rate of Kids (2026-2035)
9.2.2 Global Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth Rate of Adults (2026-2035)
10 Global Anti-Obesity Drugs Market Forecast by Geographic Region (2026-2035)
10.1 Global Anti-Obesity Drugs Sales Volume and Revenue Forecast by Geographic Region (2026-2035)
10.2 North America Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.1 United States Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.2 Canada Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3 Europe Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.1 Germany Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.2 France Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.3 United Kingdom Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.4 Spain Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.5 Russia Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.6 Poland Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4 Asia Pacific Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.1 China Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.2 Japan Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.3 South Korea Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.4 Southeast Asia Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.5 India Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.6 Australia Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5 Latin America Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.1 Mexico Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.2 Brazil Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6 Middle East and Africa Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.1 GCC Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.2 South Africa Anti-Obesity Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
Download FREE Sample